AltrixBio Raises $5 Million Series A Financing and Appoints David Pass as CEO to Advance Lead Candidate into the Clinic

- Current CEO and Co-founder Nancy Briefs Transitions to Executive Chair of the Board - - Financing and Leadership Transition Strengthen Momentum Toward First Clinical Trial of AJN 003 for Type 2 Diabetes - LOWELL, Mass., Sept. 16, 2025 /PRNewswire/ -- AltrixBio, a biopharmaceutical...